Herr Amy E. 4

Accession 0001062993-25-011400

CIK 0000842023other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:20 PM ET

Size

25.3 KB

Accession

0001062993-25-011400

Form 4

Period: 2025-06-09

Director

Transactions

Sale
Common Stock
2025-06-09$49.77/sh−1,280$63,705→ 1,976 total(indirect: By significant other)
Exercise/Conversion
Common Stock
2025-06-09$44.33/sh+1,280$56,742→ 3,256 total(indirect: By significant other)
Exercise/Conversion
Stock Option (Right to Buy)
2025-06-09−1,280→ 0 total(indirect: By significant other)
Exercise: $44.33Exp: 2025-08-08→ Common Stock (1,280 underlying)

Holdings

Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (6,636 underlying)
6,636
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (2,104 underlying)
2,104
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $72.05Exp: 2035-02-03→ Common Stock (344 underlying)
344
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (237 underlying)
237
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (480 underlying)
480
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (115 underlying)
115
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (2,076 underlying)
2,076
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (4,472 underlying)
4,472
Stock Option (Right to Buy)
Exercise: $72.05Exp: 2035-02-03→ Common Stock (2,415 underlying)
2,415
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (1,084 underlying)
1,084
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (1,468 underlying)
1,468
Common Stock
1,040

Footnotes (12)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 49.7471 to 49.8100, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F10]119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.
[F11]160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
[F12]38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
[F2]The option vests on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's annual meeting of shareholders.
[F3]Fully vested.
[F4]520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.
[F5]528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.
[F6]271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
[F7]367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
[F8]86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
[F9]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother